32 related articles for article (PubMed ID: 12825850)
1. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.
Ma X; Beeghly-Fadiel A; Lu W; Shi J; Xiang YB; Cai Q; Shen H; Shen CY; Ren Z; Matsuo K; Khoo US; Iwasaki M; Long J; Zhang B; Ji BT; Zheng Y; Wang W; Hu Z; Liu Y; Wu PE; Shieh YL; Wang S; Xie X; Ito H; Kasuga Y; Chan KY; Iwata H; Tsugane S; Gao YT; Shu XO; Moses HL; Zheng W
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1176-84. PubMed ID: 22539603
[TBL] [Abstract][Full Text] [Related]
2. One patient, two lesions, two oncogenic drivers of gastric cancer.
Alsinet C; Ranzani M; Adams DJ
Genome Biol; 2014 Aug; 15(8):444. PubMed ID: 25222187
[TBL] [Abstract][Full Text] [Related]
3. Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats.
Baker SG; Soto AM; Sonnenschein C; Cappuccio A; Potter JD; Kramer BS
BMC Cancer; 2009 Mar; 9():89. PubMed ID: 19309499
[TBL] [Abstract][Full Text] [Related]
4.
Scola L; Bongiorno MR; Forte GI; Aiello A; Accardi G; Scrimali C; Spina R; Lio D; Candore G
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886018
[TBL] [Abstract][Full Text] [Related]
5. Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway.
Bai F; Wang C; Liu X; Hollern D; Liu S; Fan C; Liu C; Ren S; Herschkowitz JI; Zhu WG; Pei XH
Cell Death Dis; 2022 Mar; 13(3):195. PubMed ID: 35236825
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
7. The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.
Schnell A; Schmidl C; Herr W; Siska PJ
Biomedicines; 2018 Feb; 6(1):. PubMed ID: 29495308
[TBL] [Abstract][Full Text] [Related]
8. Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions.
Alexander J; Cukierman E
Curr Opin Cell Biol; 2016 Oct; 42():80-93. PubMed ID: 27214794
[TBL] [Abstract][Full Text] [Related]
9. BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation.
Pickup MW; Hover LD; Polikowsky ER; Chytil A; Gorska AE; Novitskiy SV; Moses HL; Owens P
Mol Oncol; 2015 Jan; 9(1):179-91. PubMed ID: 25205038
[TBL] [Abstract][Full Text] [Related]
10. Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma.
Aprile G; Avellini C; Reni M; Mazzer M; Foltran L; Rossi D; Cereda S; Iaiza E; Fasola G; Piga A
Tumour Biol; 2013 Feb; 34(1):131-7. PubMed ID: 23007878
[TBL] [Abstract][Full Text] [Related]
11. TGF-β - an excellent servant but a bad master.
Kubiczkova L; Sedlarikova L; Hajek R; Sevcikova S
J Transl Med; 2012 Sep; 10():183. PubMed ID: 22943793
[TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
[TBL] [Abstract][Full Text] [Related]
13. Pathway analysis using random forests with bivariate node-split for survival outcomes.
Pang H; Datta D; Zhao H
Bioinformatics; 2010 Jan; 26(2):250-8. PubMed ID: 19933158
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression analysis of reactive stroma in prostate cancer.
Dakhova O; Ozen M; Creighton CJ; Li R; Ayala G; Rowley D; Ittmann M
Clin Cancer Res; 2009 Jun; 15(12):3979-89. PubMed ID: 19509179
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract][Full Text] [Related]
16. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
17. Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors.
Barlow J; Yandell D; Weaver D; Casey T; Plaut K
Breast Cancer Res Treat; 2003 May; 79(2):149-59. PubMed ID: 12825850
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.
Lücke CD; Philpott A; Metcalfe JC; Thompson AM; Hughes-Davies L; Kemp PR; Hesketh R
Cancer Res; 2001 Jan; 61(2):482-5. PubMed ID: 11212236
[TBL] [Abstract][Full Text] [Related]
19. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
